A Cost Analysis of Healthcare Episodes Including Day-Case Bariatric Surgery (Roux-en-Y Gastric Bypass and Sleeve Gastrectomy) Versus Inpatient Surgery.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
08 2022
Historique:
received: 27 01 2022
accepted: 03 06 2022
revised: 03 06 2022
pubmed: 11 6 2022
medline: 14 7 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

Assessing the medico-economic outcomes of a healthcare pathway including day-case bariatric surgery versus the conventional pathway. This economical evaluation is a prospective cohort study with historical controls. Between March 2019 and December 2020, 30 patients eligible for bariatric surgery were considered in the day-case group. Surgical procedures included sleeve gastrectomy and Roux-en-Y gastric bypass. The day-case pathway included patient education, post-discharge follow-up by a community nurse twice-daily and standardized communications to surgeons. Day-case patients were paired with 30 inpatients, based on the type of intervention, age, and ASA status. The primary outcome was the cost of care episodes from the preoperative visit to the 30-day postoperative visit. Micro-costing methodology and activity-based costing were used. Secondary outcomes included length of hospital stay, rate of unanticipated events, and patient' satisfaction assessment. Male-to-female ratio was 1/2. In the day-case versus inpatient group, age, number of associated medical conditions, and BMI (42.9 ± 4.9 versus 42.6 ± 4.6, p > 0.05) were similar. In the day-case group, there were 7 overnight stays (23.3%), 3 readmissions (10%), and 4 unscheduled consultations (13.3%). The overall length of hospital stay was significantly shorter (0.65 ± 0.33, versus 2.9 ± 0.4 days, p < 0.0001). The complication rate was 6.6% in both groups. The cost of the care episode was € 4272.9 ± 589.7 for the day-case group versus € 4993.7 ± 695.6 for inpatients, corresponding to a 14.4% cost reduction (p = 0.0254). Day-case bariatric surgery appears to be safe and beneficial in terms of costs. It involves a specific organization with postdischarge follow-up. ClinicalTrial.gov: NCT04423575.

Sections du résumé

BACKGROUND
Assessing the medico-economic outcomes of a healthcare pathway including day-case bariatric surgery versus the conventional pathway.
METHODS
This economical evaluation is a prospective cohort study with historical controls. Between March 2019 and December 2020, 30 patients eligible for bariatric surgery were considered in the day-case group. Surgical procedures included sleeve gastrectomy and Roux-en-Y gastric bypass. The day-case pathway included patient education, post-discharge follow-up by a community nurse twice-daily and standardized communications to surgeons. Day-case patients were paired with 30 inpatients, based on the type of intervention, age, and ASA status. The primary outcome was the cost of care episodes from the preoperative visit to the 30-day postoperative visit. Micro-costing methodology and activity-based costing were used. Secondary outcomes included length of hospital stay, rate of unanticipated events, and patient' satisfaction assessment.
RESULTS
Male-to-female ratio was 1/2. In the day-case versus inpatient group, age, number of associated medical conditions, and BMI (42.9 ± 4.9 versus 42.6 ± 4.6, p > 0.05) were similar. In the day-case group, there were 7 overnight stays (23.3%), 3 readmissions (10%), and 4 unscheduled consultations (13.3%). The overall length of hospital stay was significantly shorter (0.65 ± 0.33, versus 2.9 ± 0.4 days, p < 0.0001). The complication rate was 6.6% in both groups. The cost of the care episode was € 4272.9 ± 589.7 for the day-case group versus € 4993.7 ± 695.6 for inpatients, corresponding to a 14.4% cost reduction (p = 0.0254).
CONCLUSIONS
Day-case bariatric surgery appears to be safe and beneficial in terms of costs. It involves a specific organization with postdischarge follow-up.
TRIAL REGISTRATION
ClinicalTrial.gov: NCT04423575.

Identifiants

pubmed: 35689142
doi: 10.1007/s11695-022-06144-3
pii: 10.1007/s11695-022-06144-3
doi:

Banques de données

ClinicalTrials.gov
['NCT04423575']

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2504-2511

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Valérie Deschamps BS, Marion Torres, Charlotte Verdot. Étude de santé sur l’environnement, la biosurveillance, l’activité physique et la nutrition (ESTEBAN 2014–2016) Volet Nutrition. Chapitre Corpulence2017 mai 14 2020; 2017. Available from: http://www.agisante-gard.org/a/786/etude-de-sante-sur-l-environnement-la-biosurveillance-l-activite-physique-et-la-nutrition-esteban-2014-2016-volet-nutrition-chapitre-corpulence/ .
PMSI (Programme de médicalisation des systèmes d’information) 2018. In: (ATIH) Atdlislh, editor. 2018.
Friedlander DF, Krimphove MJ, Cole AP, et al. Where is the value in ambulatory versus inpatient surgery? Ann Surg. 2021;273(5):909–16.
doi: 10.1097/SLA.0000000000003578
Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248–56.
doi: 10.1002/bjs.10400
Keel G, Savage C, Rafiq M, et al. Time-driven activity-based costing in health care: a systematic review of the literature. Health Policy. 2017;121(7):755–63.
doi: 10.1016/j.healthpol.2017.04.013
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
doi: 10.1097/01.sla.0000133083.54934.ae
Cobourn C, Mumford D, Chapman MA, et al. Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg. 2010;20(4):415–22.
doi: 10.1007/s11695-009-0065-7
Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.
doi: 10.1001/jama.2020.12567
Chang SH, Freeman NLB, Lee JA, et al. Early major complications after bariatric surgery in the USA, 2003–2014: a systematic review and meta-analysis. Obes Rev. 2018;19(4):529–37.
doi: 10.1111/obr.12647
Morton JM, Winegar D, Blackstone R, et al. Is ambulatory laparoscopic Roux-en-Y gastric bypass associated with higher adverse events? Ann Surg. 2014;259(2):286–92.
doi: 10.1097/SLA.0000000000000227
Moghadamyeghaneh Z, Badami A, Masi A, et al. Unplanned readmission after outpatient laparoscopic cholecystectomy. HPB (Oxford). 2020;22(5):702–9.
doi: 10.1016/j.hpb.2019.09.005
Rosero EB, Joshi GP. Hospital readmission after ambulatory laparoscopic cholecystectomy: incidence and predictors. J Surg Res. 2017;219:108–15.
doi: 10.1016/j.jss.2017.05.071
Van Caelenberg E, De Regge M, Eeckloo K, et al. Analysis of failed discharge after ambulatory surgery: unanticipated admission. Acta Chir Belg. 2019;119(3):139–45.
doi: 10.1080/00015458.2018.1477488
Cabaton J, Thy M, Sciard D, et al. Unplanned admission after ambulatory anaesthesia in France: analysis of a database of 36,584 patients. Anaesth Crit Care Pain Med. 2021;40(1):100794.
doi: 10.1016/j.accpm.2020.100794
Sippey M, Kasten KR, Chapman WHH, et al. 30-day readmissions after sleeve gastrectomy versus Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016;12(5):991–6.
doi: 10.1016/j.soard.2016.01.036
Al-Mazrou AM, Cruz MV, Dakin G, et al. Stratification of readmission after bariatric surgery by day of post-discharge presentation. Obes Surg. 2021;31(4):1496–504.
doi: 10.1007/s11695-020-05130-x
Nguyen NT, Nguyen B, Gebhart A, et al. Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg. 2013;216(2):252–7.
doi: 10.1016/j.jamcollsurg.2012.10.003
King K, Galvez A, Stoltzfus J, et al. Cost analysis of robotic Roux-en-Y gastric bypass in a single academic center: how expensive is expensive? Obes Surg. 2020;30(12):4860–6.
doi: 10.1007/s11695-020-04881-x
El Chaar M, Gacke J, Ringold S, et al. Cost analysis of robotic sleeve gastrectomy (R-SG) compared with laparoscopic sleeve gastrectomy (L-SG) in a single academic center: debunking a myth! Surg Obes Relat Dis. 2019;15(5):675–9.
doi: 10.1016/j.soard.2019.02.012
Rebibo L, Dhahri A, Badaoui R, et al. Laparoscopic sleeve gastrectomy as day-case surgery: a case-matched study. Surg Obes Relat Dis. 2019;15(4):534–45.
doi: 10.1016/j.soard.2019.02.005

Auteurs

Mihaela Ignat (M)

Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France. DanaMihaela.IGNAT@chicas-gap.fr.
IRCAD/IHU: Institute of Image-Guided Surgery, 1 place de l'Hôpital, 67091, Strasbourg, France. DanaMihaela.IGNAT@chicas-gap.fr.
Department of Digestive Surgery, CHICAS Gap, 1 place Auguste Muret, 05000, Gap, France. DanaMihaela.IGNAT@chicas-gap.fr.

Julien Ansiaux (J)

Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France.
Department of Digestive Surgery, CHICAS Gap, 1 place Auguste Muret, 05000, Gap, France.

Samah Osailan (S)

Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France.

Antonio D'Urso (A)

Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France.
IRCAD/IHU: Institute of Image-Guided Surgery, 1 place de l'Hôpital, 67091, Strasbourg, France.

Linda Morainvillers-Sigwalt (L)

Medtronic France IHS, Bâtiment IHU, 1 Place de l'Hôpital, 67000, Strasbourg, France.

Michel Vix (M)

Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France.
IRCAD/IHU: Institute of Image-Guided Surgery, 1 place de l'Hôpital, 67091, Strasbourg, France.

Didier Mutter (D)

Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France.
IRCAD/IHU: Institute of Image-Guided Surgery, 1 place de l'Hôpital, 67091, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH